Antimicrobial resistance — new infections that are resistant to antibiotics — has been named one of the top 10 public health threats facing the world by the World Health Organization (WHO). To combat this issue, health policy experts believe that two approaches can be taken. The first is that new antibiotics should be created to treat these infections, and the second is that use of current antibiotics should be curtailed so that they are more likely to be effective for a longer period of time.
In this seminar, USC experts discuss the urgent need for a new generation of antibiotics. The panel features Genevieve Kanter, a fellow at the USC Schaeffer Center for Health Policy and Economics and professor at USC Price School of Public Policy; Brad Spellberg, chief medical officer at Los Angeles County and USC Medical Center; and Henry Skinner, CEO of AMR Action Fund. The discussion is moderated by Neeraj Sood, professor at USC Price and senior fellow at the USC Schaeffer Center.
Who Will Benefit
– Those interested in learning more about the history of antimicrobial resistance
– Health experts seeking insights on policy innovation to accelerate the development of life-saving medications
– Those hoping to understand why new antibiotics are necessary to combat infections
About Our Featured Faculty
Neeraj Sood is a professor at the USC Price School of Public Policy with joint appointments at the Keck School of Medicine of USC and USC Marshall School of Business. He is the director of COVID Initiative and a senior fellow at the USC Schaeffer Center for Health Policy and Economics. His research focuses on economic epidemiology, infectious diseases, pharmaceutical markets, health insurance, economics of innovation, Medicare and global health. He has published more 120 papers in peer-reviewed journals in economics, medicine and policy, including JAMA, Quarterly Journal of Economics, Journal of Health Economics, Health Affairs, Journal of Policy Analysis and Management and Health Services Research. He has testified frequently on health policy issues and is a national associate of the National Academies of Science, Engineering and Medicine recognizing his extraordinary contributions to the nation in matters of science, engineering and medicine.
Brad Spellberg is chief medical officer at the Los Angeles County-University of Southern California (LAC+USC) Medical Center. He received his BA in Molecular Cell Biology-Immunology from University of California, Berkeley. He then attended medical school at University of California, Los Angeles, where he received numerous academic honors, including serving as the UCLA AOA Chapter Co-President, and winning the prestigious Stafford Warren award for the topic academic performance in his graduating class. Spellberg completed his residency in internal medicine and subspecialty fellowship in infectious diseases at Harbor-UCLA Medical Center. Spellberg has extensive administrative, patient care, and teaching activities. His laboratory research focuses on the immunology, vaccinology and host defense against highly resistant bacterial and fungal infections
Genevieve Kanter is an economist whose research focuses on the regulation of biomedical technologies, industry relationships, and industry influence in medicine and provider payment models. Methodologically, she specializes in statistical methods used for causal inference. She holds a primary appointment as assistant professor at USC Price School of Public Policy and is a fellow at the USC Schaeffer Center for Health Policy and Economics. Professor Kanter received a PhD in Economics and in Sociology from the University of Chicago and completed research fellowships at Princeton University, Massachusetts General Hospital and Harvard University. Her work and essays have been published in leading medical and health policy journals, including the New England Journal of Medicine, JAMA, Health Affairs, Milbank Quarterly and the American Journal of Public Health.